Engineers Gate Manager LP Gilead Sciences, Inc. Transaction History

Engineers Gate Manager LP

$4.86 Billion
Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 30,670 shares of GILD stock, worth $2.69 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

30,670

Previous 137,892 77.76%

Holding current value

$2.69 Million

Previous $9.46 Million 72.83%

% of portfolio

0.05%

Previous 0.22%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $7.14 Million - $9.01 Million	-107,222 Reduced 77.76%	30,670 $2.57 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $5.97 Million - $6.89 Million	94,521 Added 217.94%	137,892 $9.46 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $280,164 - $341,653	-3,914 Reduced 8.28%	43,371 $3.18 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $2.08 Million - $2.36 Million	28,409 Added 150.5%	47,285 $3.83 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $2.96 Million - $3.23 Million	-40,069 Reduced 67.98%	18,876 $1.41 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $3.96 Million - $4.52 Million	52,146 Added 766.97%	58,945 $4.54 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $181,523 - $206,811	2,348 Added 52.75%	6,799 $564,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $851,478 - $1.22 Million	-13,663 Reduced 75.43%	4,451 $382,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $781,879 - $893,107	-13,132 Reduced 42.03%	18,114 $1.12 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $173,968 - $195,940	-3,014 Reduced 8.8%	31,246 $1.93 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.11 Million - $1.4 Million	19,231 Added 127.96%	34,260 $2.04 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $532,599 - $604,510	8,209 Added 120.37%	15,029 $1.09 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $461,645 - $498,064	6,820 New	6,820 $476,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $312,589 - $341,548	-4,925 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $1.95 Million - $2.23 Million	-32,535 Reduced 86.85%	4,925 $318,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $792,476 - $902,989	13,989 Added 59.6%	37,460 $2.18 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $1.27 Million - $1.59 Million	20,391 Added 662.05%	23,471 $1.48 Million
Q2 2020 Aug 17, 2020	SELL	$72.34 - $84.0 $1.61 Million - $1.86 Million	-22,201 Reduced 87.82%	3,080 $237,000
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $3.36 Million - $4.3 Million	-53,574 Reduced 67.94%	25,281 $1.89 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $2.54 Million - $2.8 Million	-41,256 Reduced 34.35%	78,855 $5.12 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.56 Million - $1.72 Million	24,934 Added 26.2%	120,111 $7.61 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $5.89 Million - $6.6 Million	95,177 New	95,177 $6.43 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Gilead Sciences, Inc. Transaction History